Altria (MO): What to Watch in Q1 2026 Earnings
Key Takeaways
- Analysts expect Q1 2026 adjusted EPS of $1.24, a slight increase from $1.23 in the year-ago quarter.
- Consensus revenue estimate stands at $4.56 billion, reflecting 0.9% year-over-year growth.
- Altria has reaffirmed its full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72, implying 2.5% to 5.5% growth.
- Investors will watch smoke-free product shipment growth, including NJOY e-vapor and on! oral nicotine pouches.
- Cigarette shipment volumes likely declined year-over-year, offset by pricing actions.
- Historical post-earnings stock reactions have been muted, with focus on guidance updates.
Why Altria's Q1 Earnings Matter
As MO navigates declining cigarette volumes due to shifting consumer preferences toward reduced-risk products, the first-quarter 2026 earnings report—due before the market open today, April 30, 2026—provides key insights into its pricing power, progress in smoke-free categories, and ability to withstand illicit trade pressures. In recent quarters, I've noted adjusted EPS growth holding up despite volume challenges, thanks to robust margins. For investors like us, this report is a test of Altria's execution on its vision to lead in smoke-free products, while it reaffirms its full-year outlook amid regulatory scrutiny and economic headwinds in the tobacco sector.
Earnings Expectations
Wall Street looks for Altria to deliver first-quarter 2026 adjusted EPS of $1.24, a modest uptick from $1.23 in Q1 2025. Consensus revenue net of excise taxes sits at $4.56 billion, up 0.9% from $4.52 billion a year ago. One thing that stands out is the expected pricing strength, which should partially offset an estimated 8-10% decline in Marlboro cigarette shipments.
Smoke-free net revenues are projected to see double-digit growth, fueled by the NJOY e-vapor brand and on! oral nicotine pouches. Altria has consistently beaten EPS estimates in recent quarters, though revenues have come in line or slightly below. I'm watching closely for reaffirmation of the full-year adjusted EPS guidance of $5.56-$5.72, which would signal confidence in cost savings and investments in smoke-free initiatives. I also checked this using Tickeron’s AI Screener to gauge how MO stacks up against industry peers on these metrics.
AI Screener
One tool I rely on for deeper market scans is Tickeron’s AI Screener. This AI-powered platform helps me filter stocks and ETFs using technical patterns, fundamentals, trends, volatility, and predictive signals. It scans thousands of assets with customizable criteria like industry, market cap, indicators, price patterns, and performance data—saving time on manual screening to spot trade ideas, breakouts, and opportunities. In my analysis of MO, it's been particularly useful for comparing smoke-free growth peers.
Market Reaction and Sentiment
Heading into earnings, sentiment around MO feels cautiously optimistic, with shares up about 5% over the past month alongside broader market gains. The stock has demonstrated resilience near $66. Risks on the table include steeper-than-expected volume drops or regulatory news on menthol cigarettes. Historically, post-earnings moves have averaged under 3%, with direction often set by guidance and smoke-free updates.
Forward Outlook and Factors to Monitor
After Q1 results, any tweaks to full-year guidance—especially toward the $5.56-$5.72 adjusted EPS range—will be critical. Altria's push into smoke-free products, targeting over $1 billion in annual revenues, hinges on metrics like NJOY's retail share and on! pouch shipments.
From what I see, broader factors like stronger enforcement against illicit vapor and cigarettes could lift reported volumes. Pricing in combustibles remains a tailwind, though input cost pressures on margins deserve attention. Key dates ahead include the annual shareholder meeting on May 14 and Q2 results in late July.
Regulatory hurdles, such as FDA moves on menthol or synthetic nicotine, remain a concern. Cost savings from the $500 million+ program should support innovation. In my view, steady smoke-free momentum and stable guidance could bolster MO's appeal as a defensive play in a market seeking yield.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
MO's Stochastic Oscillator remains in oversold zone for 3 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
MO moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MO crossed bullishly above the 50-day moving average on September 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
Following a +1.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where MO advanced for three days, in 218 of 388 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
MO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 113 of 283 cases where MO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 40%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MO as a result. In 35 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 43%.
The Moving Average Convergence Divergence Histogram (MACD) for MO turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 21 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 36%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.253) is normal, around the industry mean (16.498). P/E Ratio (14.554) is within average values for comparable stocks, (19.513). Projected Growth (PEG Ratio) (2.649) is also within normal values, averaging (3.595). Dividend Yield (0.062) settles around the average of (0.037) among similar stocks. MO's P/S Ratio (5.744) is slightly higher than the industry average of (2.780).
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. MO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company which produces and markets tobacco products
Industry Tobacco
Advertisement